Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2010 1
2012 1
2013 1
2014 2
2015 2
2016 1
2017 10
2018 9
2019 17
2020 15
2021 27
2022 24
2023 24
2024 22
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the treatment of systemic sclerosis: 2023 update.
Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, Suliman YA, Matucci-Cerinic M, Gabrielli A, Distler O, Hoffmann-Vold AM, Castellví I, Balbir-Gurman A, Vonk M, Ananyeva L, Rednic S, Tarasova A, Ostojic P, Boyadzhieva V, El Aoufy K, Farrington S, Galetti I, Denton CP, Kowal-Bielecka O, Mueller-Ladner U, Allanore Y. Del Galdo F, et al. Among authors: lescoat a. Ann Rheum Dis. 2025 Jan;84(1):29-40. doi: 10.1136/ard-2024-226430. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39874231 Free article.
[Tolerating uncertainty: Towards a competence-based approach].
Belhomme N, Lescoat A, Launey Y, Jégo P, Cavalin C, Pottier P. Belhomme N, et al. Among authors: lescoat a. Rev Med Interne. 2023 Jan;44(1):27-30. doi: 10.1016/j.revmed.2022.10.387. Epub 2022 Nov 10. Rev Med Interne. 2023. PMID: 36371326 Free article. French.
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A, Jouneau S, Jego P, Vernhet L, Batteux F, Fardel O, Lecureur V. Lescoat A, et al. Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17. Biochem Pharmacol. 2020. PMID: 32562787 Free article.
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y; EUSTAR collaborators. Lescoat A, et al. JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729. JAMA Dermatol. 2023. PMID: 37378994 Free PMC article.
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.
Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, Riemekasten G, Distler JHW, Rosato E, Del Galdo F, Mendoza FA, Furst DE, de la Puente C, Hoffmann-Vold AM, Gabrielli A, Distler O, Bloch-Queyrat C, Allanore Y; EUSTAR collaborators. Elhai M, et al. Lancet Rheumatol. 2022 Nov;4(11):e785-e794. doi: 10.1016/S2665-9913(22)00217-X. Lancet Rheumatol. 2022. PMID: 38265945
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study.
Trottet C, Schürch M, Allam A, Petelytska L, Castellví I, Bečvář R, de Vries-Bouwstra J, Iannone F, Carreira P, Truchetet ME, Cuomo G, Rezus E, Cantatore FP, Simeón-Aznar CP, Parvu M, Dzhus M, Distler O, Hoffmann-Vold AM, Krauthammer M; EUSTAR Collaborators. Trottet C, et al. NPJ Digit Med. 2025 Sep 1;8(1):563. doi: 10.1038/s41746-025-01962-y. NPJ Digit Med. 2025. PMID: 40890392 Free PMC article.
151 results